3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
15
Lung Neoplasms
13
Urinary Bladder Neoplasms
11
Ovarian Neoplasms
8
Non-Muscle Invasive Bladder Neoplasms
6
Neoplasm Metastasis
5
Colorectal Neoplasms
5
Cholangiocarcinoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Lymphoma, Large B-Cell, Diffuse
4
Fallopian Tube Neoplasms
4
Breast Neoplasms
4
Biliary Tract Neoplasms
4
Triple Negative Breast Neoplasms
3
Nasopharyngeal Carcinoma
3
Melanoma
3
Recurrence
2
Rectal Neoplasms
2
Osteosarcoma
2
Lymphoma, Follicular
2
Gallbladder Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Transitional Cell
2
Bile Duct Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Urologic Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
Specimen Handling
3
fludarabine
2
aldesleukin
2
Sunitinib
2
Fluorouracil
2
Cyclophosphamide
2
Bevacizumab
2
trastuzumab deruxtecan
1
sodium propionate
1
semaglutide
1
repotrectinib
1
patritumab deruxtecan
1
isosorbide-5-mononitrate
1
fludarabine phosphate
1
dehydroftorafur
1
Tomography, X-Ray Computed
1
Radiosurgery
1
Positron-Emission Tomography
1
Photography
1
Pemetrexed
1
Pafolacianine
1
Memantine
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Leucovorin
1
Isosorbide
1
Irinotecan
1
Interleukin-2
1
IDRX-42
1
High-Intensity Interval Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Gemcitabine
×
30 days
×
Clear all
No trials found.